Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. uri icon

authors

  • Cohen, Jordana B
  • Corrales-Medina, Vicente
  • Andrade-Villanueva, Jaime F
  • Barbagelata, Alejandro
  • Cristodulo-Cortez, Roberto
  • Díaz-Cucho, Omar A
  • Spaak, Jonas
  • Alfonso, Carlos E
  • Valdivia-Vega, Renzo
  • Villavicencio-Carranza, Mirko
  • Ayala-García, Ricardo J
  • Hanff, Thomas C
  • Castro-Callirgos, Carlos A
  • González-Hernández, Luz A
  • Bernales-Salas, Eduardo F
  • Coacalla-Guerra, Johanna C
  • Salinas-Herrera, Cynthia D
  • Nicolosi, Liliana
  • Basconcel, Mauro
  • Byrd, James B
  • Sharkoski, Tiffany
  • Bendezú-Huasasquiche, Luis E
  • William, Preethi
  • Chittams, Jesse
  • Edmonston, Daniel L
  • Vasquez, Charles R
  • Julio A. Chirinos, MD, PhD
  • Sweitzer, Nancy
  • Rosado-Santander, Nelson R
  • Medina, Carola
  • Rodriguez-Mori, Juan E
  • Renna, Nicolás
  • Chang, Tara I

publication date

  • January 7, 2021